Securities code: Hvsen Biotechnology Co.Ltd(300871) securities abbreviation: Hvsen Biotechnology Co.Ltd(300871) Announcement No.: 2022021 convertible bond Code: 123132 convertible bond abbreviation: Huisheng convertible bond
Hvsen Biotechnology Co.Ltd(300871)
About the company and its subsidiaries applying for comprehensive credit line from financial institutions and
Announcement of relevant guarantee matters
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Hvsen Biotechnology Co.Ltd(300871) (hereinafter referred to as “the company”) held the 23rd Meeting of the second board of directors on March 10, 2022, which deliberated and approved the company’s proposal on the application of the company and its subsidiaries for comprehensive credit line and related guarantees from financial institutions, which needs to be submitted to the 2021 annual general meeting of shareholders for deliberation. The relevant information is hereby announced as follows:
1、 Application for comprehensive credit line
In order to meet the production, operation and project investment needs of the company and its subsidiaries, the company and its subsidiaries Hubei Hvsen Biotechnology Co.Ltd(300871) Technology Co., Ltd. and Wuhan Xinhua Star Animal Health Chain Service Co., Ltd. plan to apply for comprehensive credit from banks and other financial institutions in 2022, with a line of no more than RMB 700 million. The financing methods include but are not limited to bank working capital loans, fixed asset investment loans Letter of guarantee, letter of credit, acceptance bill, bill discount, factoring, etc. The above credit line is subject to the actual approval of the bank and is not equal to the actual financing amount of the company. The actual financing amount should be within the credit line, subject to the actual financing amount of financial institutions. The specific financing amount will be reasonably determined according to the actual needs of the company’s working capital, and the actual credit line of each bank can be adjusted with each other within the total credit line. During the credit period, the credit line can be recycled. The company and its subsidiaries provide guarantees for the above credit facilities.
2、 Provision of guarantee
Guarantee amount of the guaranteed party
The proportion of net asset guarantee in the latest related case rate (note) (10000 yuan) (10000 yuan) of the company holding the newly added guarantee amount of the guaranteed balance of assets and liabilities of the share ratio of the guaranteed party of the listed company in the latest period up to now
Hubei Huisheng
Wuhan Hui biotechnology 100% 60.32% 11369324100000 25.33% Fusheng biology Co., Ltd
Technology stocks Wuhan Xinhua
Limited animal insurance 82.04%
No, the chain asset ratio of Health Service Co., Ltd. exceeds 9000.5% (the negative asset ratio of Health Service Co., Ltd. exceeds 100.00%)
Division (70%)
Listed companies guarantee a total of 12203665000000 30.89% for subsidiaries
Huisheng Zigong, Wuhan, Hubei
Sheng Biotechnology Department
Technology Co., Ltd. listed 34.60% 8437522000000 12.35% no limited company
guarantee
Subsidiary guarantees for listed companies totaling 8437522000000 12.35%
Note: the asset liability ratio in the above table is the audited data as of December 31, 2021.
The above guarantee amount is not equal to the actual guarantee amount of the company and its subsidiaries. The actual guarantee amount within the guarantee amount shall be subject to the actual loan amount between banks and other financial institutions and the company and subsidiaries, and the guarantee period shall be subject to the guarantee liability period agreed in the specifically signed guarantee contract. In order to facilitate the smooth progress of the company’s application for credit line from the bank, the specific credit guarantee matters within the above credit line will be submitted to the general meeting of shareholders, and the chairman of the company will be authorized to organize the implementation, review and sign the relevant documents within the above credit line from the date of passing the above matters, without convening the general meeting of shareholders and the board of directors. For the credit guarantee beyond the above limit, the company will consider and make a resolution separately in accordance with relevant regulations. The authorization period starts from the date when the proposal is reviewed and approved by the 2021 annual general meeting of shareholders to the date of the next annual general meeting of shareholders. (II) basic information of the guaranteed company
1. Basic information of Hubei Hvsen Biotechnology Co.Ltd(300871) Technology Co., Ltd. (1)
Name: Hubei Hvsen Biotechnology Co.Ltd(300871) Technology Co., Ltd
Date of establishment: April 8, 2009
Registered at Hengyi Road, Chengnan Economic Development Zone
Legal representative: Yu Hujie
Registered capital: 300 million yuan
Production and manufacturing of veterinary drugs, feed and feed additives, special chemical products and fertilizers; Main business: research and development of bio organic fertilizer, bio feed and microbial fertilizer; Sales of feed additives and animal husbandry and fishery feeds
Equity structure: the company holds 100% equity of Hubei Hvsen Biotechnology Co.Ltd(300871) Technology Co., Ltd
Affiliated relationship Hvsen Biotechnology Co.Ltd(300871) wholly owned subsidiary
Whether it is a dishonest executee no
(2) Financial situation: the main financial indicators of the latest year and period are as follows:
Unit: 10000 yuan
December 31, 2021 December 31, 2020
Total assets 83484954439846
Total liabilities 50359222612938
Net assets 33125731826908
Project year 2021 to 2020
Operating income 33845642620904
Total profit 369423416356
34334444 net profit
2. Wuhan xinhuaxing animal health chain service Co., Ltd
(1) Basic information
Name: Wuhan xinhuaxing animal health chain service Co., Ltd
Date of establishment: September 4, 2007
Registration place: No. 218, Zhangbai Road, Dongxihu District, Wuhan
Legal representative: Liu Zexiang
The registered capital is 12 million yuan
Main business: Sales of veterinary drugs, non compulsory immune veterinary biological products, fertilizers and class I medical devices; Wholesale and retail of feed and additives
Equity structure the company holds 100% equity of Wuhan Xinhua Star Animal Health Chain Service Co., Ltd
Affiliated relationship Hvsen Biotechnology Co.Ltd(300871) wholly owned subsidiary
Whether it is a dishonest executee no
(2) Financial situation:
The main financial indicators of the company in the latest year and period are as follows:
Unit: 10000 yuan
December 31, 2021 December 31, 2020
Total assets 462308395746
Total liabilities 379267319838
Net assets 830.42 759.09
Project year 2021 to 2020
Operating income 16962071641917
Total profit 71.88 216.62
Net profit 69.20 199.39
3、 Main contents of credit and guarantee agreement
At present, the company has not signed relevant credit and guarantee agreements with banks and other financial institutions. The above credit line is only the credit line to be applied by the company. The specific credit amount shall be subject to the contract signed when the bank borrows according to the actual capital needs of the company.
4、 Opinions of the board of directors
The board of Directors believes that the company and its subsidiaries applied for comprehensive credit line from banks and other financial institutions in 2022, and the company provided guarantees for its subsidiaries and subsidiaries to meet the normal capital turnover needs of the company and its subsidiaries in production and operation, help to improve the company’s performance, and the risk is controllable, which is in line with the company’s development strategy, laws and regulations The regulations and the articles of association will not damage the interests of the company and all shareholders.
5、 Accumulated external guarantees and overdue guarantees
As of the disclosure date of this announcement, the total amount of external guarantees provided by listed companies was 503589400 yuan, and the balance of external guarantees was 1220366 million yuan, which were all guarantees provided for wholly-owned subsidiaries, accounting for 7.54% of the audited net assets of the company in 2021. The company and its subsidiaries have no overdue external guarantee or litigation guarantee.
6、 Documents for future reference
Resolution of the 23rd Meeting of the second board of directors.
It is hereby announced.
Hvsen Biotechnology Co.Ltd(300871) board of directors March 11, 2022
